Previous investigations have shown that BRRM effectively reduces BC risk [7–12, 24, 25], but convincing data regarding survival after BRRM in BRCA1/2 mutation carriers are scarce and mainly derived from modeling studies. The gene discussed is BRCA1; the disease is breast cancer.